VIGILVESTLibrary
← Library

Moderna, Inc.

MRNA
SEC CIK 1682852Price charts ↗
Writing the earnings story…

Financials

Revenue+260.2% YoY
$389.0M
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Net Income+38.3% YoY
-$1.34B
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
EPS (diluted)+34.9% YoY
-$3.4
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Gross Margin
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Quarter endingRevenueNet incomeEPS
Mar 2026$389.0M-$1.34B-$3.4
Sep 2025$1.02B-$200.0M-$0.51
Jun 2025$142.0M-$825.0M-$2.13
Mar 2025$108.0M-$971.0M-$2.52
Sep 2024$1.86B$13.0M$0.03
Jun 2024$241.0M-$1.28B-$3.33
Mar 2024$167.0M-$1.18B-$3.07
Sep 2023$1.83B-$3.63B-$9.53

Annual revenue

FY21FY22FY23FY24FY25

Source filings

Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.

Glossary

Revenue
Net income
EPS
Gross margin
Net margin
Fiscal year

Hover any underlined term for its definition.